<DOC>
	<DOCNO>NCT01631474</DOCNO>
	<brief_summary>CB-03-01 develop topical treatment acne vulgaris , androgen-dependent skin disorder . The purpose study compare safety efficacy multiple concentration CB-03-01 vehicle treatment acne vulgaris .</brief_summary>
	<brief_title>A Phase 2 Dose Escalating Study Evaluate Safety Efficacy CB-03-01 Cream Subjects With Facial Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Subject male nonpregnant female . Females must postmenopausal , surgically sterile use highly effective birth control method . Subject provide write verbal informed consent/assent . Subject facial acne vulgaris ( include nose ) . Subject willing comply study instruction return clinic require visit . Subject use type brand makeup , facial product ( include cleanser ) hair product ( e.g. , shampoo , gel , hair spray , mousse , etc . ) least one month prior study start agrees continue his/her general skin hair care product regimen entire study . Subject pregnant , lactating , plan become pregnant study . Subject currently enrol investigational drug device study . Subject receive investigational drug treat investigational device within 30 day prior study start . Subject need plan expose artificial tanning device excessive sunlight trial Subject use follow topical antiacne preparation procedure face : Topical antiacne treatment include limited overthecounter acne cleaner treatment , benzoyl peroxide , antibiotic , azelaic acid , sulfa base product , corticosteroid salicylic acid within two week initiation treatment . Retinoids , include tazarotene , adapalene , tretinoin , within four week initiation treatment . Light treatment , microdermabrasion chemical peel within eight week initiation treatment . Subject use follow systemic antiacne medication : Corticosteroids ( include intramuscular intralesional injection ) within four week initiation treatment . Inhaled , intranasal ocular corticosteroid allow use stable ( stable use define dose frequency unchanged least four week prior initiation treatment ) . Antibiotics within four week initiation treatment exception five day less antibiotic therapy period , antibiotic use permit within one week prior initiation treatment . Spironolactone within eight week initiation treatment exception five day less spironolactone therapy period , spironolactone use permit within one week prior initiation treatment . Retinoid therapy within six month initiation treatment .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Intrepid</keyword>
	<keyword>acne</keyword>
	<keyword>antiandrogen</keyword>
</DOC>